Abiogen Pharma, a Pisa, Italy-based pharmaceutical manufacturing company, acquired Altamedics GmbH, a Cologne, Germany-based company that focuses on the distribution of pharmaceuticals in hospital settings, as well as of specialty and high-value-added products.
The amount of the deal was not disclosed.
With the acquisition, Abiogen Pharma will expand its offerings.
Altamedics GmbH distributes pharmaceuticals, namely hospital products, on the domestic and on several international markets, via third-party manufacturing sites and its warehouse and logistics centre in Neunkirchen. With operations in 15 countries through its partners, Altamedics’ key figures currently include approximately 3 million euros in revenue and 6 employees.
Led by CEO Massimo Di Martino, Abiogen Pharma spans across several integrated areas: research and development, manufacturing of pharmaceuticals with its own brand or under third-party contracts, and marketing of own and licensed drugs. Its target therapeutic areas include bone metabolism, pain treatment, as well as respiratory, metabolic and dermatological disorders. With 195 million euros in revenue and 450 employees, it ranks among the 15 largest Italian pharmaceutical companies.
FinSMEs
11/12/2022